Local news outlets including WKBW, WGRZ, The Lockport Journal and WIVB report that UB spinoff company POP Biotechnologies and biotech company EuBiologics have developed a COVID-19 vaccine candidate that has entered clinical trials in South Korea.
Business First reported that a COVID-19 vaccine developed by UB and Buffalo-based startup POP Biotechnologies has entered human clinical trials in South Korea.
Gizmodo quotes Albert Titus, professor and chair of biomedical engineering, in a story asking experts to explain whether wearable technologies accurately track calorie-burn.
From celebrating the life of a Buffalo civil rights activist to resurrecting a mammoth’s broken genes, here are stories from the work of UB researchers in a difficult year.
The medical device trade websites, Mass Device and Medical Design & Outsourcing, report that UB spinoff company Garwood Medical Devices has received a $749,000 federal grant to evaluate if its BioPrax medical device can prevent, control, and eliminate bacterial biofilm infections associated with orthopedic implants.
His innovative research spans an array of fields including artificial vision, artificial neural networks, optoelectronics and integrated sensor systems.
